SciELO - Scientific Electronic Library Online

 
vol.30 número5Angiectasias intestinais: existe um verdadeiro impacto na sobrevida? índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


GE-Portuguese Journal of Gastroenterology

versão impressa ISSN 2341-4545

Resumo

ABREU, Nélia; PEREIRA, Vítor Magno; PESTANA, Madalena  e  JASMINS, Luís. Future Perspectives in the Diagnosis and Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency. GE Port J Gastroenterol [online]. 2023, vol.30, n.5, pp.1-9.  Epub 01-Dez-2023. ISSN 2341-4545.  https://doi.org/10.1159/000528809.

Alpha-1 antitrypsin deficiency (AATD) is one of the most common genetic diseases and is caused by mutations in the SERPINA1 gene. The homozygous Pi*Z variant is responsible for the majority of the classic severe form of alpha-1 antitrypsin deficiency, which is characterized by markedly decreased levels of serum alpha-1 antitrypsin (AAT) with a strong predisposition to lung and liver disease. The diagnosis and early treatment of AATD-associated liver disease are challenges in clinical practice. In this review, the authors aim to summarize the current evidence of the non-invasive methods in the assessment of liver fibrosis, as well as to elucidate the main therapeutic strategies under investigation that may emerge in the near future.

Palavras-chave : Alpha-1 antitrypsin; Liver disease; Treatment.

        · resumo em Português     · texto em Inglês     · Inglês ( pdf )